ImmunityBio (IBRX) Operating Income Growth (1y) (2015 - 2026)
ImmunityBio (IBRX) Operating Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 1,386.07% |
| 10 | ImmunityBio | 7.15 Bn | 6.77 Bn | 43.97 Mn | -8.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.32% |
| Dec 31, 2025 | 6.80% |
| Sep 30, 2025 | 30.68% |
| Jun 30, 2025 | 28.24% |
| Mar 31, 2025 | 32.32% |
| Dec 31, 2024 | 18.72% |
| Sep 30, 2024 | -0.15% |
| Jun 30, 2024 | -16.66% |
| Mar 31, 2024 | 14.68% |
| Dec 31, 2023 | -0.58% |
| Sep 30, 2023 | 11.75% |
| Jun 30, 2023 | -6.94% |
| Mar 31, 2023 | -16.26% |
| Dec 31, 2022 | -7.10% |
| Sep 30, 2022 | -15.18% |
| Jun 30, 2022 | 7.31% |
| Mar 31, 2022 | -11.25% |
| Dec 31, 2021 | -156.67% |
| Sep 30, 2021 | -19.67% |
| Jun 30, 2021 | -68.72% |